Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D.
Equistatin from sea anemone is a protein composed of three thyroglobulin-type 1 domains known to inhibit papain-like cysteine proteinases, papain, and cathepsins B and L. Limited proteolysis was used to dissect equistatin into a first domain, eq d-1, and a combined second and third domain, eq d-2,3. Only the N-terminal domain inhibits papain (Ki = 0.61 nM). Remarkably, equistatin also strongly inhibits cathepsin D with Ki = 0.3 nM but not other aspartic proteinases such as pepsin, chymosin, and HIV-PR. This activity resides on the eq d-2,3 domains (Ki = 0.4 nM). Papain and cathepsin D can be bound and inhibited simultaneously by equistatin at pH 4.5, confirming the physical separation of the two binding sites. Equistatin is the first inhibitor of animal origin known to inhibit cathepsin D. The obtained results demonstrate that the widely distributed thyroglobulin type-1 domains can support a variety of functions.
Lenarcic
B
B
Department of Biochemistry and Molecular Biology, J. Stefan Institute, Jamova 39, 1000 Ljubljana, Slovenia. brigita.lenarcic@ijs.si
Turk
V
V
D000595:Amino Acid Sequence; D000818:Animals; D002402:Cathepsin D / Q000037:antagonists & inhibitors*; D002851:Chromatography, High Pressure Liquid; D006868:Hydrolysis; D007700:Kinetics; D010206:Papain / Q000037:antagonists & inhibitors*; D011506:Proteins / Q000737:chemistry / Q000378:metabolism*; D013552:Swine; D013954:Thyroglobulin / Q000378:metabolism*
D011506:Proteins; C106356:equistatin; D013954:Thyroglobulin; D010206:Papain; D002402:Cathepsin D